Published in Biotech Business Week, December 26th, 2005
"Biotech is shaping up to have an exceptional year. With 1 month to go, the 18.5% increase in the Burrill Biotech Select Index compared with NASDAQ's 2.6% and the Dow's less than 1% gains since the beginning of the year is an incredible testimony to the successful industry's year," said G. Steven Burrill, CEO of Burrill & Company, a San Francisco based global leader in life sciences with principal activities in Venture Capital, Merchant Banking and Media.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.